Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide.

Alzheimer disease Aβ42/Aβ40 ratio Fourier transform IR (FTIR) amyloid precursor protein (APP) amyloid-beta (Aβ) fluorescence membrane interaction neurodegeneration nuclear magnetic resonance (NMR) secretase

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
12 04 2019
Historique:
received: 07 10 2018
revised: 09 02 2019
pubmed: 14 2 2019
medline: 15 10 2019
entrez: 14 2 2019
Statut: ppublish

Résumé

Extracellular deposition of β-amyloid (Aβ) peptides in the brain is a hallmark of Alzheimer's disease (AD). Upon β-secretase-mediated cleavage of the β C-terminal fragment (β-CTF) from the Aβ precursor protein, the γ-secretase complex produces the Aβ peptides associated with AD. The familial T43I mutation within the transmembrane domain of the β-CTF (also referred to as C99) increases the ratio between the Aβ42 and Aβ40 peptides largely due to a decrease in Aβ40 formation. Aβ42 is the principal component of amyloid deposits within the brain parenchyma, and an increase in the Aβ42/Aβ40 ratio is correlated with early-onset AD. Using NMR and FTIR spectroscopy, here we addressed how the T43I substitution influences the structure of C55, the minimal sequence containing the entire extracellular and transmembrane (TM) domains of C99 needed for γ-secretase processing.

Identifiants

pubmed: 30755484
pii: S0021-9258(20)36658-8
doi: 10.1074/jbc.RA118.006061
pmc: PMC6463720
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
Peptide Fragments 0
Peptides 0
amyloid beta-protein (1-40) 0
amyloid beta-protein (1-42) 0
Amyloid Precursor Protein Secretases EC 3.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5854-5866

Subventions

Organisme : NIA NIH HHS
ID : R01 AG027317
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG027317
Pays : United States

Informations de copyright

© 2019 Tang et al.

Références

J Biol Chem. 1992 Jan 5;267(1):546-54
pubmed: 1730616
Science. 1999 Oct 22;286(5440):735-41
pubmed: 10531052
J Am Chem Soc. 2013 Jan 30;135(4):1317-29
pubmed: 23265086
Biochemistry. 2015 Oct 13;54(40):6149-52
pubmed: 26403946
Science. 2019 Feb 15;363(6428):
pubmed: 30630874
Am J Hum Genet. 1992 Nov;51(5):998-1014
pubmed: 1415269
Hum Mol Genet. 1997 Nov;6(12):2087-9
pubmed: 9328472
Arch Neurol. 2000 Jun;57(6):885-7
pubmed: 10867787
J Biol Chem. 1991 Sep 5;266(25):16960-4
pubmed: 1909332
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1421-6
pubmed: 19164538
Sci Rep. 2017 Dec 7;7(1):17159
pubmed: 29215043
Trends Biochem Sci. 2015 Jun;40(6):318-27
pubmed: 25941170
J Biol Chem. 2009 Oct 16;284(42):28943-52
pubmed: 19596858
Nature. 1991 Oct 31;353(6347):844-6
pubmed: 1944558
J Biol Chem. 2007 Mar 30;282(13):9952-9961
pubmed: 17259179
Nature. 1991 Feb 21;349(6311):704-6
pubmed: 1671712
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4119-24
pubmed: 10097173
Hum Mol Genet. 2001 Aug 1;10(16):1665-71
pubmed: 11487570
EMBO J. 2007 Mar 21;26(6):1702-12
pubmed: 17332749
Nature. 2019 Jan;565(7738):192-197
pubmed: 30598546
Elife. 2016 Aug 31;5:
pubmed: 27580372
Ann Neurol. 2000 Feb;47(2):249-53
pubmed: 10665499
Science. 1990 Jun 1;248(4959):1124-6
pubmed: 2111584
Nat Commun. 2014;5:3037
pubmed: 24390130
Biophys J. 2002 May;82(5):2476-86
pubmed: 11964235
Nat Struct Mol Biol. 2010 Feb;17(2):151-8
pubmed: 20062056
Biophys J. 2015 Mar 10;108(5):1229-37
pubmed: 25762334
Elife. 2015 Dec 01;4:
pubmed: 26623517
Ann Neurol. 2001 Jun;49(6):697-705
pubmed: 11409420
Structure. 2014 Mar 4;22(3):387-96
pubmed: 24462250
Cell Discov. 2016 Aug 23;2:16026
pubmed: 27625790
Science. 2012 Jun 1;336(6085):1168-71
pubmed: 22654059
ACS Omega. 2017 Oct 09;2(10):6525-6534
pubmed: 31457253
Nat Genet. 1992 Jun;1(3):218-21
pubmed: 1303239
Acta Neuropathol. 2010 Aug;120(2):185-93
pubmed: 20419305
Hum Mol Genet. 2000 Nov 1;9(18):2589-98
pubmed: 11063718
J Biol Chem. 2017 Sep 22;292(38):15826-15837
pubmed: 28790170
Neurology. 2002 May 28;58(10):1574-5
pubmed: 12034808
EMBO J. 2016 Aug 1;35(15):1628-43
pubmed: 27220847
Biochemistry. 2008 Sep 9;47(36):9428-46
pubmed: 18702528
FEBS Lett. 2012 Jun 12;586(12):1687-92
pubmed: 22584060
Biochemistry. 2013 Jul 30;52(30):5051-64
pubmed: 23865807
J Neurol. 2003 Nov;250(11):1374-5
pubmed: 14648157
BMC Neurosci. 2008 Jan 30;9:17
pubmed: 18234110
Cell. 2017 Jul 27;170(3):443-456.e14
pubmed: 28753424

Auteurs

Tzu-Chun Tang (TC)

From the Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York 11794-5215.

Pascal Kienlen-Campard (P)

the Institute of Neuroscience, Université Catholique de Louvain, Brussels 1200, Belgium.

Yi Hu (Y)

From the Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York 11794-5215.

Florian Perrin (F)

Ludwig Institute for Cancer Research and de Duve Institute, Université Catholique de Louvain, Brussels 1200, Belgium.

Rémi Opsomer (R)

the Institute of Neuroscience, Université Catholique de Louvain, Brussels 1200, Belgium.

Jean-Noël Octave (JN)

the Institute of Neuroscience, Université Catholique de Louvain, Brussels 1200, Belgium.

Stefan N Constantinescu (SN)

Ludwig Institute for Cancer Research and de Duve Institute, Université Catholique de Louvain, Brussels 1200, Belgium.

Steven O Smith (SO)

From the Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York 11794-5215. Electronic address: steven.o.smith@stonybrook.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH